Special Issue on Cancer Immunotherapy

Cancer Immunotherapy is the use of the immune system to reject cancer by stimulating the patient's immune system to attack the malignant tumor cells that are responsible for the disease. This can be either through immunization of the patient, in which case the patient's own immune system is trained to recognize tumor cells as targets to be destroyed, or through the administration of therapeutic antibodies as drugs, in which case the patient's immune system is recruited to destroy tumor cells by the therapeutic antibodies. There are many therapies under application: cell-based immunotherapy, monoclonal antibody therapy, interferon etc.

In this special issue, we intend to invite front-line researchers and authors to submit original researches and review articles on exploring cancer immunotherapy. Potential topics include, but are not limited to:

• Mechanisms of immunotherapy
• Indications of cancer immunotherapy
• Cell-based immunotherapy
• Application of monoclonal antibody in immunotherapy
• Application of interferon in immunotherapy
• Application of natural products in immunotherapy
• Advances in cancer immunotherapy

Authors should read over the journal’s Authors’ Guidelines carefully before submission. Prospective authors should submit an electronic copy of their complete manuscript through the journal’s Paper Submission System.

Please kindly notice that the “Special Issue” under your manuscript title is supposed to be specified and the research field “Special Issue - Cancer Immunotherapy” should be chosen during your submission.

According to the following timetable:

Guest Editor:

For further questions or inquiries

Please contact Editorial Assistant at

jct@scirp.org